Phillip Taboada/X
Aug 26, 2025, 09:56
Phillip Taboada: TXA Shows No Added Benefit in Aquablation
Phillip Taboada, MS4 at UT Southwestern Medical Center and urology applicant, posted on X:
”New work in New work in Canadian J Urology.
Limited TUR during Aquablation provides adequate hemostasis. TXA offered no clear benefit in reducing hematuria or transfusions.
Thanks UT Southwestern Urology for the support!”
Read the full article here.
Title: Tranexamic acid and hematuria outcomes following aquablation for benign prostatic hyperplasia
Authors: Phillip Taboada, Rohit R. Badia, Dhillon Advano, Andrew Murphy, Christina Sze, Ryan J. Mauck, Jennifer Tse, Jeffrey Gahan, Claus G. Roehrborn, Ramy Goueli

Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jul 11, 2026, 18:12Dianne E. van der Wal: A Thought-Provoking Discussion on Immunothrombosis at ISTH 2026
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders
-
Jul 11, 2026, 15:03Dino Mehic: Paris Welcomes the Global Hemostasis Community at ISTH 2026
-
Jul 11, 2026, 14:55Carsten Deppermann: An Inspiring Perspective on Scientific Discovery
-
Jul 11, 2026, 14:47Isabella Presch: Arrived in Amazing Paris For ISTH 2026
-
Jul 11, 2026, 14:12Riten Kumar: The Opening Day Experience at ISTH 2026
-
Jul 11, 2026, 13:44Mary Cushman: A Decade After the RPTH Journal Launch at ISTH 2026
-
Jul 11, 2026, 11:31Acute DVT Management and the Role of Interventions Beyond Anticoagulation: Insights From ISTH 2026